Introduction
Ventilator-associated pneumonia (VAP) is a common nosocomial infection in intensive care units (ICUs) . VAP is defined as pneumonia that occurs 48 h or more after endotracheal intubation or tracheostomy, caused by infectious agents not present or incubating at the time mechanical ventilation was started. It can be of two types: (i) earlyonset VAP which is defined as VAP that Ventilator-associated pneumonia (VAP) is the most common nosocomial infection diagnosed in the intensive care unit (ICU) and in spite of advances in diagnostic techniques and management it remains a common cause of hospital morbidity and mortality. While critically ill patients experience a life-threatening illness, they commonly contract ventilator-associated pneumonia. This nosocomial infection increases morbidity and likely mortality as well as the cost of health care. This article reviews the literature with regard to underlying clinical condition, prevalence, diagnosis and antibiotic susceptibility pattern of the most commonly isolated pathogens associated with VAP. This prospective observational study was carried out over a period of 1 year. VAP was diagnosed using the clinical pulmonary infection score. Endotracheal aspirate (ETA) and bronchoalveolar lavage (BAL) samples of suspected cases of VAP were collected from ICU patients and processed as per standard protocols. The incidence of VAP in our study was 57.27%. COPD was the commonest underlying condition associated with VAP followed by post operative illness & respiratory failure. The incidence of VAP increased as the duration of mechanical ventilation increased and there was a total agreement in bacteriology between semi-quantitative ETAs and BALs in our study. Most commonly isolated organism was Acinetobacter baumanii followed by Pseudomonas aeruginosa and Klebseilla pneumoniae. The present study conclude that determination of the organism profile and their antibiotic sensitivity can go a long way in prescribing appropriate regimen which could be life saving. Another important aspect in VAP group of patients is that if the antibiotic therapy is delayed, there could be excessive mortality. Early report regarding antibiotic susceptibility patterns could be significant in deciding the antibiotic regimens. VAP is a serious problem in the ICU leading to longer hospital stay higher treatment costs and increased mortality and morbidity. Better knowledge of local patterns of pathogens causing VAP can help facilitate treatment choices. occurs within the first 4 days of ventilation, and (ii) late-onset VAP which is defined as VAP that occurs more than 4 days after initiation of mechanical ventilation. 1 The objective of this study is to describe the microbiology of VAP in tertiary-care hospital ICU of Jhalawar, Rajasthan for a period of one year. Intensive care unit (ICU) hospitalisations impose a high risk of acquiring healthcareassociated infection (HAIs), most commonly nosocomial pneumonia. It is necessary to understand how and when the ICU admitted, mechanically ventilated patients develop VAP and which micro-organisms are responsible for causing VAP. The microorganisms responsible for VAP and their drug resistance vary between individual hospitals wards, between regions of a state and across India. Thus, there is a need for local surveillance data, taking into account a detailed analysis of etiologic agents responsible for VAP. VAP requires rapid diagnosis and initiation of the appropriate antibiotic treatment, since studies have shown that the delayed administration of appropriate antibiotic therapy in patients with VAP has been associated with excess hospital mortality. 2 Therefore, our objective is to determine the incidence of VAP, to assess the risk factors and attributable mortality associated with VAP and to find out the various bacterial pathogens causing VAP in the medical ICU of our institute.
Materials and Methods
This prospective, observational study was done in the Department of Microbiology, Jhalawar Medical College, in association with the tertiary care teaching hospital of Jhalawar, Rajasthan for a period of 1 year (Aug 2017-Aug 2018). All symptomatic patients on mechanical ventilation for more than 48hrs admitted in the medical and surgical ICUs were taken for study. Modified clinical pulmonary infection score (CPIS) score was then studied as a screening method to clinically diagnose VAP. Detailed history including the name, age, sex, underlying clinical condition, date of admission to the ICU, date of indoor admission, any history of previous antibiotic intake, the treatment being administered in the ICU and clinical outcome of each patient was noted. Any lower respiratory tract infection that developed after 48 h of mechanical ventilation and was judged not to have been incubating before mechanical ventilation was taken as VAP.
VAP rate was defined as the number of VAPs/1,000 ventilator days. The diagnosis of VAP was based on clinical and microbiological criteria. A clinical suspicion of VAP was made in patients with modified CPIS score >6. Broncho-alveolar lavage (BAL) was taken as the sample of interest for diagnosing VAP. Gram stain preparations were made from all BAL samples and examined first under low power to determine the presence and type of cells in the specimen and then observed under oil immersion field. The relative number of micro-organisms and their morphologies were recorded. All the samples were inoculated semi-quantitatively on blood agar, MacConkey agar and chocolate agar and incubated aerobically at 37*C. Growth >105 CFU/ml was taken as the cut-off threshold for BAL. Samples showing growth less than these thresholds were assumed to be due to colonisation or contamination. In case of significant growth, the isolated colonies were subjected to gram stain. Identification and AST pattern of bacterial isolates thus obtained from 110 intensive-care hospitalised patients were processed on Vitek 2 system (Biomerieux, France).
Results and Discussion
Out of the 110 VAP suspected ICU admitted patients, samples of 63 patients yielded bacterial growth. The incidence of VAP in our study was 57.27%. Out of the 63 cases, 19% developed early VAP whereas 38% developed late VAP. Highest number of patients developing VAP was due to COPD (17/21). 2nd most common cause for development of VAP was due to post operative illness (19/30). Likewise, respiratory failure (16/27), trauma (4/10), poisoning (1/7) and miscellaneous (6/15) were amongst the other causes. In relation to gender, the incidence of VAP was more among males (63%) than females (36%) and in different age groups the incidence of VAP was highest in patients more than 55 years of age (76.19%).
Gram negative bacteriae were the most commonly isolated pathogens responsible for VAP. Amongst them, Acinetobacter baumanii was found to be the single most common organism isolated (21/63 In 2010, Gadani et al., concluded that the order of prevalence of organism in their study was found to be Pseudomonas (43.2%), Klebsiella (18.91%), followed by MRSA, E. coli, Acinetobacter, MSSA and S. pneumoniae. 10 In the present study, Chronic Obstructive Pulmonary Disorder (COPD) stood out as the most common underlying condition leading to VAP, followed by post operative stay in ICU, respiratory failure, trauma and chronic ailments like diabetes mellitus, chronic renal diseases, Neurological diseases, hepatic diseases. In 2017, Li Chang et al., observed that age > 65 years, smoke, coronary heart disease, diabetes, chronic obstructive pulmonary disease (COPD), ICU and hospital stay, and days on mechanical ventilation were risk factors of VAP, with age >65 years being the most common risk factor 11 ( Fig. 1 and Table 1 and 3). The present study conclude that determination of the organism profile and their antibiotic sensitivity can go a long way in prescribing appropriate regimen which could be life saving. Another important aspect in VAP group of patients is that if the antibiotic therapy is delayed, there could be excessive mortality. Early report regarding antibiotic susceptibility patterns could be significant in deciding the antibiotic regimens. VAP is a serious problem in the ICU leading to longer hospital stay higher treatment costs and increased mortality and morbidity. Better knowledge of local patterns of pathogens causing VAP can help facilitate treatment choices. Local data collected the similar studies can assist in making informed treatment choices. To conclude, VAP due to a MDR Acinetobacter is one of the most dreadful complications that occur in the critical care setting. This poses serious problems in choosing the right antibiotic for the treatment of sick patients admitted into the ICU. Various strategies such as strict infection control measures, judicious prescribing of antibiotics, antibiotic resistance surveillance programs and antibiotic cycling are crucial to control infections due to these bacteria in patients admitted to ICU. throughout in the journey of completion of this paper, my colleagues, technicians and other laboratory staff for helping me with the minutest detail while researching this article. I would also like to thank the Ethical Committee of my institution for giving me timely approval and permission to conduct the research.
